Fangzhou Inc. Garners Prestigious "Most Valued Pharmaceutical & Healthcare Enterprise" Award

December 16, 2024 11:13 AM CET | By Cision
 Fangzhou Inc. Garners Prestigious
Image source: Kalkine Media

SHENZHEN, China, Dec. 16, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was honored with a "Most Valued Pharmaceutical & Healthcare Enterprise" award at the grand "9th Zhitong Finance Capital Market Summit and Listed Company Gala" held in Shenzhen, China.

Mr. Xie Fangmin, Chairman and CEO of Fangzhou, stated, "We are honored to receive this award. This recognition underscores our dedication to advancing technological innovation and supporting the high-quality development of the Internet healthcare industry."

A "Most Valued Pharmaceutical & Healthcare Enterprise" award is bestowed upon exceptional pharmaceutical and healthcare companies listed in Hong Kong and the United States, recognizing their robust corporate governance, industry leadership, and strong business performance.

As a pioneer in the Internet healthcare sector, Fangzhou has been listed on the main board of the Hong Kong Stock Exchange since July 2024 and was included in the Hang Seng Hong Kong-Listed Biotech Index ("HSHKBIO") as of December 9, 2024.

Since its inception, Fangzhou has focused on leveraging advanced technologies, including AI technology and big data, to enhance its chronic disease management platform and provide patients and doctors a better user experience. Receiving this award highlights the Company's strong industry recognition, and its ongoing commitment to driving innovation in the online healthcare sector.

About Fangzhou Inc.
Fangzhou Inc. (06086.HK) is China's leading online chronic disease management platform. With 45.6 million registered users and 217,000 registered doctors on its platform (as of June 30, 2024), the Company provides tailored medical care and precision medicine for a growing population of chronic disease patients. For more details, visit https://investors.jianke.com.

About the Zhitong Finance Capital Market Summit and Listed Company Gala
The "9th Zhitong Finance Capital Market Summit and Listed Company Gala " was jointly hosted by Zhitong Finance, a leading Hong Kong and U.S. stock information platform, and New Wisdom Fund Network, a one-stop service platform for Chinese overseas private equity funds. The conference gathered representatives from top domestic and international financial institutions and chief economists, along with over 300 senior executives from Hong Kong and U.S. stock listed companies, 100+ US equity funds and more than 1,000 professional investors, collectively exploring investment opportunities in Chinese assets in 2025. Over its nine consecutive years of successful hosting, the summit has garnered significant acclaim and influence in the nation's capital markets.

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: [email protected] 

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Sponsored Articles